Skip to main content

Table 1 Patient characteristics and therapy for CI associated with adenomyosis

From: “Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report”

Case

Age (y.o.)

D-dimer (μg/ml)

FDP (μg/ml)

CA125 (U/ml)

hemoglobin (g/dl)

treatment for CI

treatment for adenomyosis

recurrence of CI

reference

initial treatment

subsequent treatment

1

45

1.1

159

8.4

hepalin

antipletelet therapy

GnRH agonist

Yamashiro K et al. 2012

2

44

5.9

7

hepalin

warfalin

GnRH agonist

3

50

0.57

42.6

6.9

aspirin

GnRH agonist

4

42

6.0

1750

8.6

antiplatelet therapy

warfalin

GnRH agonist

+

5

59

7.0

334.8

antithrombotic therapy

Hijikata N et al. 2016